It utilizes a high-pressure balloon to break up the blockages and open the vessels to help maintain arteriovenous access in the peripheral vascular system. Medtronic - medical technology – has ...
Covidien's Fortrex percutaneous transluminal angioplasty balloon catheter--Courtesy of Covidien Covidien ($COV) today announced FDA 510(k) clearance for its Fortrex ...
Prevention or correction of anemia possibly reduces the progression of lower extremity peripheral arterial disease in patients receiving hemodialysis. Anemia appears to be an independent risk factor ...
Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis. Although clinical history in conjunction with ankle–brachial index and evaluation of segmental ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In patients with dysfunctional hemodialysis arteriovenous fistulae, adding a drug-coated balloon to ...
THE advent of long-term hemodialysis and renal transplantation has focused attention upon the peripheral neuropathy associated with chronic renal insufficiency. 1–4 Although the initial clinical ...
San Francisco, CA—In a study originally designed to address the efficacy of using bicarbonate for the prevention of acute kidney injury in patients undergoing angiography, data presented at TCT 2013 ...
Medtronic plc 's MDT Peripheral Vascular business is set to get a boost with the recent U.S. launch of the Fortrex over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback